Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Apr 22 2021

· Issued by Caplin Point Laboratories Limited

Filed with NSE ·

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated April 22, 2021, titled "Caplin Steriles gets USFDA approval for NeostigmineMethylsulfate Injection".

View Attachment

6ix hasn’t read this filing yet.

Caplin Point Laboratories Limited on 6ix

Earlier from Caplin Point Laboratories

Later from Caplin Point Laboratories

All Caplin Point Laboratories news releases